For all readers, more than 90% presented with good or excellent overall lesion visualization and characterization with either of the two contrast agents.1
Rate of patients with overall lesion visualization and characterization scored good/excellent or poor/fair
![](/media/n5llkwrr/remind-chart-01.jpg)
![](/media/uxnj1tch/remind-chart-btm-1.jpg)
Additionally, in most cases there was no preference of the readers for either contrast agent regarding border delineation, internal morphology, and the qualitative degree of contrast enhancement despite quantitative mean lesion percentage enhancement being higher with gadobutrol.1
Border Delineation
![](/media/bc0gciet/remind-chart-02.png)
![](/media/qcxnyq2x/remind-chart-btm-2-md-borderd.png)
Internal Morphology
![](/media/mwzli1nf/remind-chart-03.png)
![](/media/qcxnyq2x/remind-chart-btm-2-md-borderd.png)
Degree of Contrast Enhancement
![](/media/eszfmxwq/remind-chart-04.png)
![](/media/qcxnyq2x/remind-chart-btm-2-md-borderd.png)